Northwire Canada EditionThursday, October 15, 2026
Northwire
⌕
GOLD 4170.00 +1.5% SILVER 57.19 +2.3% COPPER 6.56 −1.6% OIL 98.09 +3.1% PALLADIUM 1131.00 +3.1% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.180 −16.3% CLCH 1.09 −0.9% NSU 0.170 +9.7% WM 0.085 +0.0% YGT 0.175 +2.9% EVI 0.520 +4.0% ADZ 0.125 +0.0% MINK 0.075 +0.0% DNO 0.300 +0.0% RRRL 0.150 +0.0% MTT 0.245 +0.0% BAU 0.180 −5.3% TECT 1.67 +0.6% TOM 0.140 +3.7% GOLD 4170.00 +1.5% SILVER 57.19 +2.3% COPPER 6.56 −1.6% OIL 98.09 +3.1% PALLADIUM 1131.00 +3.1% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.180 −16.3% CLCH 1.09 −0.9% NSU 0.170 +9.7% WM 0.085 +0.0% YGT 0.175 +2.9% EVI 0.520 +4.0% ADZ 0.125 +0.0% MINK 0.075 +0.0% DNO 0.300 +0.0% RRRL 0.150 +0.0% MTT 0.245 +0.0% BAU 0.180 −5.3% TECT 1.67 +0.6% TOM 0.140 +3.7%
Financings

QScreen arranges $500,000 private placement

QAI · Price

Executive Summary

  • QScreen AI Inc. has arranged a non-brokered private placement to raise up to $500,000 in gross proceeds.
  • The company intends to issue up to 10 million units at a price of $0.05 per unit.
  • Proceeds will be used to advance commercialization initiatives, including pilot discussions and operational integration, as well as to support working capital requirements.

Key Details

  • Transaction Structure: Non-brokered private placement.
  • Units Offered: Up to 10,000,000 units.
  • Price Per Unit: $0.05.
  • Gross Proceeds: Up to $500,000.
  • Unit Composition: Each unit consists of one common share and one-half of one common share purchase warrant.
  • Warrant Terms:
    • Each warrant entitles the holder to purchase one-half of a common share.
    • Exercise Price: $0.15 per half-share.
    • Term: 36 months following the closing date.
    • Acceleration Clause: If the volume-weighted average price (VWAP) of common shares on the Canadian Securities Exchange is equal to or greater than $0.30 for any 10 consecutive trading days (starting four months and one day after closing), the company may accelerate the warrant expiry date to 30 days following written notice to holders.
  • Use of Proceeds:
    • Advancing structured pilot discussions and operational integration planning with select organizations.
    • Supporting working capital requirements associated with scaling commercialization efforts across enterprise-scale health care, industrial, and technology sectors.
  • Market Interest: Preliminary indications of interest have been received from select investors.

Notable Quotes

  • None provided in the text.
Read the original news release →

More from QScreen AI Inc